We are seeking participants for a clinical research study.
This study is testing whether Kinisquin (isoquercetin with vitamins C and B3) can help prevent blood clots in people with metastatic pancreatic cancer starting chemotherapy.
Adults (18+) with metastatic pancreatic cancer who are starting or have recently started first-line chemotherapy (within the last 30 days).
Note: Additional eligibility criteria apply.
Join the fight against metastatic pancreatic cancer and help advance research.